Skip to main content
Have a personal or library account? Click to login
Comparison between hypoxic markers pimonidazole and glucose transporter 1 (Glut-1) in murine fibrosarcoma tumours after electrochemotherapy Cover

Comparison between hypoxic markers pimonidazole and glucose transporter 1 (Glut-1) in murine fibrosarcoma tumours after electrochemotherapy

Open Access
|Sep 2009

References

  1. Kranjc S, Cemazar M, Grosel A, Sentjurc M, Sersa G. Radisensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells in tumors in mice.2005;: 115.
  2. Teicher BA. Acute and chronic in vivo therapeutic resistence.2009;: 1665-73.
  3. Rademakers SE, Span PN, Kaanders J, Swep F, van der Kogel AJ, Bussink J. Molecular aspects of tumour hypoxia.2008;: 41-53.
  4. Mayer A, Höckel M, Wree A, Vaupel P. Lack of correlation between expression of HIF-1α protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix.2004;: 5876-81.
  5. Russell J, Carlin S, Burke SA, Wen B, Yang KM, Ling CC. Immunohistochemical detection of changes in tumor hypoxia.2009;: 1177-86.
  6. Raleigh JA, Chou SC, Bono EL, Thral DE, Varia MA. Semiquantitative immunohistochemical analysis for hypoxia in human tumours.2001;: 569-74.
  7. Nordsmark M, Loncaster J, Chou SC, Hacsteen H, Lidegaard JC, Davidson SE, et al. Invasive oxygen measurements and pimonidazole labelling in human cervix carcinoma.2001;: 581-6.
  8. Sakata K, Someya M, Nagakura H, Nakata K, Oouchi A, Hareyama M, et al. A clinical study of hypoxia using endogenous hypoxic markers and polarographic oxygen electrodes.2006;: 511-7.
  9. Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A. Regulation of glut-1 mRNA by hypoxia inducible factor-1.2001;: 9519-25.
  10. Cooper R, Sarioglu S, Sökmen S, Füzün M, Küpelioglu A, Valentine A, et al. Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma.2003;: 870-6.
  11. Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma.2008;: 388-98.
  12. Sun X, Li XF, Russell J, Xing L, Urano M, Li GC, et al. Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dualtracer immunohistochemistry.2008;: 269-76.
  13. Airley RE, Philips RM, Evans AE, Double J, Burger AM, Feibig HH, et al. Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (first translational award) study of the relevance of tumour-hypoxia to the outcome of chemotherapy in human tumour derived xenografts.2005;: 1477-84.
  14. Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, et al. Glut-1 and CAIX as intrinsic markers of hypoxial in carcinoma of the cervix: Relationship to pimonidazole binding.2003;: 85-91.
  15. Jarm T, Sersa G, Miklavcic D. Oxygenation and blood flow in tumours treated with hydralazine: Evaluation with a novel luminescence-based fiberopric sensor.2002;: 363-80.
  16. Kennedy AS, Raleigh JA, Perez GM, Calkins DP, Thrall DE, Novotny DB, et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.1997;: 897-905.
  17. Olive PL, Durand RE, Raleigh JA, Luo C, Aquino-Parsons C. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.2000;: 1525-31.
  18. He F, Deng X, Wen B, Liu Y, Sun X, Xing L, et al. Nonivasive molecular imaging of hypoxia in human xenografrts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.2008;: 8597-606.
  19. Gulliksnud K, Vestvik IK, Galapathi K, Rofstad EK. Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry.2008;: 638-50.
  20. Rajaganeshan R, Prased R, Guillou PJ, Poston G, Scott N, Jayne DG. The role of hypoxia in recurrence following resection of Dukes'B colorectal cancer.2008;: 1049-55.
  21. Yasuda M, Miyazawa M, Fujita M, Kajiwara H, Iida T, Hirasawa T, et al. Expression of hypoxia inducible factor 1-alfa (HAF-1alfa) and glucose transporter 1 (GLUT-1) in ovarian adenocarcinoma difference in hypoxic status depending on histological character.2008;: 111-6.
  22. Hoskin PJ, Sibtain A, Daley FM, Wilson GD. GLUT 1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.2003;: 1290-7.
  23. Kunkel M, Moergel M, Stockinger M, Joeng JH, Fritz G, Lehr HA, et al. Overexpression of Glut-1 is associated with resistence to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity.2007;: 796-803.
  24. Mayer A, Hockel M, Wree A, Vaupel P. Microregional expression of glucose transporter 1 and oxygenation status lack of correlation in locally advanced cervical cancer.2005;: 2768-73.
  25. Hedley D, Pintilie M, Woo J, Morrison A, Birle D, Fyles A, et al. Carbonic anhidrase IXexpression, hypoxia, and progression in patients with uterin cervical carcinomas.2003;: 566-74.
  26. Jankovic B, Aquino-Persons C, Raleigh JA. Comparison between pimonidazole binding oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.2006;: 45-55.
  27. Koukourakis MI, Giatromanolaki A, Sivridis E, Pastorek J, Karapantzos I, Gatter KC, et al. Hypoxia-actovated tumor pathways of angiogenesis and regulation of pH independent of anemia in head-and-neck cancer.2004;: 67-71.
  28. Kostourou V, Troy H, Murray JF, Cullis ER, Whitley GS, Griffiths JR, et al. Overexpression of dimethylarginine dimethylaminohydrolase enhances tumour hypoxia: An insight into the relationship of hypoxia and angiogenesis in vivo.2004;: 401-11.
  29. Teissie J, Escoffre JM, Rols MP, Golzio M. Time dependence of electric field effects on cell membranes. A review for a critical selection of pulse duration for therapeutical applications.2008;: 196-206.
  30. Zupancic A, Corovic S, Miklavcic D. Optimization of electrode position and electric pulse amplitude in electrochemotherapy.2008;: 93-101.
  31. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, et al. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin.2002;: 1047-54.
DOI: https://doi.org/10.2478/v10019-009-0029-5 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 195 - 202
Published on: Sep 14, 2009
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2009 Andrej Cör, Maja Cemazar, Nadja Plazar, Gregor Sersa, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.